Cannabis Stock News: Aphria (TSX.V: $APH) (OTCQB: $APHQF) Continues
Success Story With TSX Listing
Listing increases access to capital and growing investor base interested
in burgeoning cannabis industry
LEAMINGTON, ONTARIO-- March 21, 2017 - Aphria Inc.
("Aphria" or the "Company") ((TSX Venture: APH) (OTCQB:APHQF), a Health Canada
Licensed Producer of medical cannabis products, today announced that the common
shares (the "Common Shares") of the Company will begin trading on the
Toronto Stock Exchange ("TSX") as of the open of the market on March
22, 2017. The Common Shares will continue to trade under the symbol
"APH". In conjunction with listing on the TSX, the Common Shares will
be voluntarily delisted from the TSX Venture Exchange prior to the commencement
of trading on March 22, 2017.
"Aphria's listing on the TSX represents a major
milestone in our strategic growth plan, helping to increase trading liquidity,
access a growing investor base interested in the cannabis industry, and raise
capital for further investments," said Vic Neufeld, Chief Executive
Officer, Aphria. "As one of Canada's leading cannabis companies, we are excited
about the opportunities in this rapidly growing market to drive shareholder
value and continue Aphria's success story. The TSX is the premier listings
destination and this achievement highlights the strength of our experienced
management and team, our commitment to providing safe, quality products and our
positive growth trajectory."
Backed by over 35 years of experience in agriculture
and over 20 years in the pharmaceutical space, Aphria is one of the lowest cost
producers in the industry. In January 2017, the Company announced that its
Board approved a $137 million capital project to increase Aphria's capacity
greenhouse growing footprint capacity from 300,000 square feet to 1 million
square feet, positioning the Company to support continued mid-term demand
expectations and growth as the market for cannabis expands.
We Have a Good Thing Growing.
Read this release in full at http://www.investorideas.com/420cannabisinvestorideas/Companies/APH/news/2017/03211Success.asp
About Aphria
Aphria Inc., one of Canada's lowest cost producers,
produces, supplies and sells medical cannabis. Located in Leamington, Ontario,
the greenhouse capital of Canada. Aphria is truly powered by sunlight, allowing
for the most natural growing conditions available. We are committed to
providing pharma-grade medical cannabis, superior patient care while balancing
patient economics and returns to shareholders. We are the first public licensed
producer to report positive cash flow from operations and the first to report
positive earnings in consecutive quarters. For more information, visit www.Aphria.com.
CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain information in this news release constitutes
forward-looking statements under applicable securities laws. Any statements
that are contained in this news release that are not statements of historical
fact may be deemed to be forward-looking statements. Forward looking statements
are often identified by terms such as "may", "should",
"anticipate", "expect", "potential",
"believe", "intend" or the negative of these terms and
similar expressions. Forward-looking statements in this news release include,
but are not limited to, statements with respect to internal expectations,
access to capital and expectations for future liquidity, expectations for
future growing capacity and costs, the completion of any capital project or
expansions, any commentary related to the legalization of marijuana and the
timing related thereto, expectations of Health Canada approvals and
expectations with respect to future production costs. Forward-looking
statements necessarily involve known and unknown risks, including, without
limitation, risks associated with general economic conditions; adverse industry
events; marketing costs; loss of markets; future legislative and regulatory
developments involving medical marijuana; inability to access sufficient
capital from internal and external sources, and/or inability to access
sufficient capital on favourable terms; the medical marijuana industry in
Canada generally, income tax and regulatory matters; the ability of Aphria to
implement its business strategies; competition; crop failure; currency and
interest rate fluctuations and other risks.
Readers are cautioned that the foregoing list is not
exhaustive. Readers are further cautioned not to place undue reliance on
forward-looking statements as there can be no assurance that the plans,
intentions or expectations upon which they are placed will occur. Such
information, although considered reasonable by management at the time of
preparation, may prove to be incorrect and actual results may differ materially
from those anticipated.
Forward-looking statements contained in this news
release are expressly qualified by this cautionary statement.
Neither the TSX Venture Exchange (the
"Exchange") nor its Regulation Services Provider (as that term is
defined in the policies of the Exchange) accepts responsibility for the
adequacy or accuracy of this release.
Contact Information
Nina Godard
Media Relations
416.455.6324
Vic Neufeld
CEO
Disclosure:
Aphria Inc. ("Aphria" or the "Company") (TSX VENTURE:APH)
(OTCQB:APHQF) is a featured company on the 420 Cannabis Investor Ideas of 2017
at www.420cannabisinvestorideas.com
Disclaimer/Disclosure:
Investorideas.com is a digital publisher of third party sourced news, articles
and equity research as well as creates original content, including video,
interviews and articles. Original content created by investorideas is protected
by copyright laws other than syndication rights. Our site does not make
recommendations for purchases or sale of stocks, services or products. Nothing
on our sites should be construed as an offer or solicitation to buy or sell
products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated for news publication and
distribution, social media and marketing, content creation and more. Contact
each company directly regarding content and press release questions. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Disclosure: Companies Featured on the 420 Cannabis Investor Ideas have paid a
one-time fee of Up to $1000 to be featured on the directory
Additional
info regarding BC Residents and global Investors: Effective September 15 2008 -
all BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.
Global investors must adhere to regulations of each country.
No comments:
Post a Comment